Medical Imaging (MEDD) 10-Q 17 Jun 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Jun. 11, 2015
Document And Entity Information
Entity Registrant Name	MEDICAL IMAGING CORP.
Entity Central Index Key	1370804
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		24,166,481
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current Assets
Cash and Cash Equivalents	$57,518	$188,206
Accounts Receivable, net	1,012,587	851,884
Prepaid Expenses	23,364	24,165
Total Current Assets	1,093,469	1,064,255
Property and Equipment
Equipment	3,429,457	3,402,671
Less: Accumulated Depreciation	-594,103	-463,977
Total Property and Equipment, net	2,835,354	2,938,694
Goodwill	1,977,670	1,977,670
Other Assets
Deposits	12,091	12,463
Loan Receivable	0	1,497
Total Other Assets	12,091	13,960
TOTAL ASSETS	5,918,584	5,994,579
Current Liabilities
Accounts Payable	642,625	624,141
Accrued Taxes Payable	336,160	311,547
Obligations Under Capital Lease, short term portion	207,774	189,923
Promissory Notes, short term portion	228,050	134,999
Royalty Financing, short term portion	103,234	102,219
Convertible Notes, net short term portion	2,014,487	54,263
Total Current Liabilities	3,532,330	1,417,092
Long Term Liabilities
Obligations Under Capital Lease, long term portion	428,790	459,853
Royalty Financing, long term portion	1,947,907	1,902,698
Convertible Notes, net, long term portion	399,944	2,332,708
Total Long Term Liabilities	2,776,641	4,695,259
Total Liabilities	6,308,971	6,112,351
Stockholders' Deficit
Preferred Stock	0	0
Common Stock	24,167	23,947
Additional Paid-In Capital	1,970,223	1,876,484
Accumulated Other Comprehensive Gain	40,790	21,393
Accumulated Deficit	-2,425,567	-2,039,596
Total Stockholders' Deficit	-390,387	-117,772
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$5,918,584	$5,994,579

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value in dollars	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value in dollars	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	24,166,481	23,946,481
Common stock, shares outstanding	24,166,481	23,946,481

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenue:
Sales	$1,820,517	$1,195,937
Less: Cost of Sales	951,466	705,495
Gross Margin	869,051	490,442
Operating Expenses:
Advertising	9,516	16,523
Amortization	0	22,925
Depreciation	135,724	39,820
Bad Debt Expense (Recapture)	0	7,522
General and Administrative	188,802	54,523
Insurance	24,950	11,746
Labor	331,771	190,480
Legal and Professional	142,895	41,226
Management Fees	18,313	4,422
Rent Office Space and Servers	132,693	39,136
Travel	8,515	14,388
Total Operating Expenses	993,179	442,711
Income (Loss) from Operations	-124,128	47,731
Other Income and (Expenses):
Other Income	6,024	160
Foreign Currency Gains (Losses)	2,236	415
Amortization of Debt Discount	-112,291	-20,356
Interest Expense	-157,812	-68,225
Total Other Income (Expenses)	-261,843	-88,006
Income (Loss) Before Provision for Income (Taxes) Credit	-385,971	-40,275
Provision for Income (Taxes) Credit	0	0
Net Income (Loss)	-385,971	-40,275
Other Comprehensive Income	19,397	1,065
Total Comprehensive Income (Loss)	($366,574)	($39,210)
Basic and Diluted Income (Loss) per Share	($0.02)	($0.00)
Weighted Average Shares Outstanding - Basic and Diluted	24,098,259	23,350,793

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	($385,971)	($40,275)
Adjustments to Reconcile Net Loss to Net Cash provided by Operating Activities:
Depreciation	135,724	39,820
Asset Write Off	0	974
Accrued Interest Converted into note	0	61,832
Amortization of Debt Discount	112,291	20,356
Stock-based compensation	92,919	150
Amortization of Intangible Assets	0	22,925
Foreign currency transaction Gain/ Loss	519	229
Changes in operating assets and liabilities:
Accounts Receivable	-160,703	107
Deposits and prepaid expenses	801	-3,042
Accounts Payable and accrued liabilities	114,653	-68,239
Loans Receivable	1,497	280
NET CASH AND CASH EQUIVALENTS PROVIDED (USED) BY OPERATING ACTIVITIES	-88,270	35,117
CASH FLOWS FROM INVESTING ACTIVITIES:
Equipment Purchase	-12,488	0
NET CASH USED IN INVESTING ACTIVITIES	-12,488	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from debt issuance	374,000	300,000
Principal payments on debt	-390,072	-73,560
Principal Payments on Capital Lease Obligations	-33,255	-16,300
NET CASH AND CASH EQUIVALENTS PROVIDED (USED) BY IN FINANCING ACTIVITIES	-49,327	210,140
Gain (Loss) due to foreign currency translation	19,397	1,065
NET CHANGE IN CASH AND CASH EQUIVALENTS	-130,688	246,322
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	188,206	77,300
CASH AND CASH EQUIVALENTS AT END OF PERIOD	57,518	323,622
Cash paid during the year for:
Interest	157,812	6,393
Income Taxes	17,308	18,900
Non-cash financing and investing activities:
Shares Issued for Convertible Note	1,040	25,500
Equipment purchase under capital lease	20,043	0
Accrued Interest converted to Note	$75,039	$0

Organization_and_Summary_of_Si

Organization and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	Note 1. Organization and Summary of Significant Accounting Policies
	Organization and Basis of Presentation
	Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania. In 2014, the company purchased Partners Imaging Center of Venice, LLC (“PIV”) located in Venice, Florida; Partners Imaging Center of Naples, LLC (“PIN”) located in Naples, Florida; and Partners Imaging Center of Charlotte, LLC (“PIC”) located in Port Charlotte, Florida.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
	Principle of Consolidation
	The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions (March 2, 2009, December 10, 2012, and November 1, 2014, respectively) are not included in the consolidated balance sheet.
	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the March 31, 2015 presentation.
	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2015, and December 31, 2014, cash includes cash on hand and cash in the bank.
	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. As of March 31, 2015 and December 31, 2014, the allowance for bad debts was $64,673.
	Bad debt expense for the three months ended March 31, 2015 and 2014 was $0 and $7,522, respectively.
	As of March 31, 2015 two customers of CTS totalled approximately 12% of the total accounts receivable. As of December 31, 2014, three customers totalled approximately 16% of the total accounts receivable.
	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisitions date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. As of March 31, 2015, the Company has goodwill of $1,422,670 as result of the acquisition of SMI on December 10, 2012. $132,143, $158,571, and $264,286 as a result of the acquisitions of PIC, PIN, PIV, respectively, that occurred on October 31, 2014. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the three months ended March 31, 2015, CTS held seven contracts; one contract that is renewable on a year-to-year basis, three contracts that are renewable in 2014 ,2015, and 2016, and its largest contract, which renewed automatically in 2013 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, PIV, PIN, and PIC revenue is recorded at the time of service
	Cost of Sales
	Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs.
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	3 - 7 years           Equipment
	5– 7 years           Furniture and Fixtures
	3 - 5 years           Non-compete Contract
	39 years              Leasehold Improvements
	Stock Based Compensation
	The company follows ASC 718 to produce an estimated fair value.
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
	The Company recognized stock-based compensation expenses of $34,683 and $0 from stock options granted to non-employees for the three months ended March 31, 2015 and 2014.
	The stock based compensation for the three months ended March 31, 2015 pertains to stock options granted to non-employee. The options were valued using the BOPM and included in the Legal and professional operating expenses in the consolidated statements of operations.
	The Company recognized stock-based compensation expenses of $58,236, and $0 from stock and stock options granted to employees for the three months ended March 31, 2015, and 2014, respectively.
	The stock based compensation for the three months ended March 31, 2015 includes stock options granted to employees of $47,896. The options were valued using the BOPM and included in the Labor and management fees operating expenses in the consolidated statements of operations.
	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1  Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2  Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
	Level 3  Pricing inputs that are generally observable inputs and not corroborated by market data.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
	The company does not have assets and liabilities that are carried at fair value on a recurring basis.
	Foreign Currency Translation
	The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
	The Company recognized a foreign currency gain on transactions from operations of $2,236 and $415 for the three months ended March 31, 2015 and 2014, respectively.
	The Company recognized other comprehensive gain of $19,397 and $1,065 for the three months ended March 31, 2015 and 2014, respectively.
	Income Taxes
	The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
	Net Income (Loss) Per Share
	The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
	Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive. As of March 31, 2015, there were no stock options or stock awards that would have been included in the computation of diluted earnings per share that could potentially dilute basic earnings per share in the future.
	The information related to basic and diluted earnings per share is as follows:
		Three Months Ended
		March 31,		March 31,
2015		2014
Numerator:
Continuing operations:
Total Comprehensive Income (Loss)	$	-366,574	$	-39,210
Total	$	-366,574	$	-39,210
Total Comprehensive Income (Loss)	$	-366,574	$	-39,210
Denominator:
Weighted average number of shares outstanding – basic and diluted		24,098,259		23,350,793
EPS:
Basic:
Total Comprehensive Income (Loss)	$	-0.015	$	-0.002
Net Income (loss)	$	-0.015	$	-0.002
Diluted
Total Comprehensive Income (Loss)	$	-0.015	$	-0.002
Total Comprehensive Income (Loss)	$	-0.015	$	-0.002
Recent Accounting Updates
The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Interim_Financial_Statements

Interim Financial Statements	3 Months Ended
	Mar. 31, 2015
Quarterly Financial Information Disclosure [Abstract]
Interim Financial Statements	Note 2. Interim Financial Statements
	The accompanying interim unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

Property_and_Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 3. Property and Equipment
	For the three months ended, March 31, 2015 the company has acquired additional computer equipment of $ 32,531 for its CTS subsidiary.
	For the year ended December 31, 2014, the Company has completed the purchase of a CT and an X-ray machine for its SMI location. SMI has purchased a 16 Slice Toshiba Aquillion CT for $198,000 and a Viztek Digital Direct Radiography Straight Arm x-ray System for $78,250. In addition SMI has completed building CT and x-ray rooms to house the additional machines; the additions in leasehold improvements were for a total of $96,470. SMI has acquired a new PACS/RIS system for $162,333.
	As part of the November 1, 2014 acquisitions of PIV, PIN, and PIC clinics the company has acquired Medical equipment of $1,245,000.
	For the year ended December 31, 2014 the company has acquired additional computer equipment of $25,108 for its PIV, PIN, PIN location, as well as a new PACS/RIS system for $167,107.
	Property and equipment are stated at cost. Depreciation is calculated using the straight - line method over the estimated useful life of the assets. At March 31, 2015 and December 31, 2014, the major class of property and equipment were as follows:
		March 31,		December 31,		Estimated useful lives
		2015		2014
	Computer/Office Equipment	$	462,652	$	435,867	3-7 years
	Medical Equipment		2,123,024		2,123,023	3-7 years
	Leasehold Improvements		843,781		843,781	39 years
	Less: Accumulated Depreciation		-594,103		-463,977
	Net Book Value	$	2,835,354	$	2,938,694
	Depreciation expense was $135,724 and $39,820 for the three months ended March 31, 2015 and 2014, respectively.

Business_Combination

Business Combination	3 Months Ended
	Mar. 31, 2015
Business Combinations [Abstract]
Business Combination	Note 4. Business Combination
	On October 31, 2014, the Company acquired 100% of the shares of three separate entities, Partners Imaging Center of Venice, LLC, Partners Imaging Center of Naples, LLC, and Partners Imaging Center of Charlotte, LLC., for an aggregate cash consideration described in detail below. Each company was purchased for its medical equipment, general office fixtures, Medicare number and facility lease. There were no prior earnings, accounts receivable, accounts payable, or other assets or liabilities acquired in any of the acquisitions. Medical imaging services began to be offered on November 1, 2014 by PIV, PIN, and PIC.
	The Company paid an aggregate purchase price of $1,800,000 as follows (at fair value):
		Total		PIV	PIN	PIC
	Cash	$	1,800,000	959,286	533,571	307,143
	Total consideration paid	$	1,800,000	959,286	533,571	307,143
	The following assets and liabilities were recognized (at fair value):
		Total		PIV	PIN	PIC
	Fixed Assets	$	1,245,000	695,000	375,000	175,000
	Goodwill		555,000	264,286	158,571	132,143
	Net assets purchased	$	1,800,000	959,286	533,571	307,143
	The Company has evaluated the transactions and believes that the historical cost of the tangible and intangible assets acquired approximated the fair market value given the current nature of the assets acquired. As part of the acquisitions the company has acquired aggregate Goodwill of $555,000. The company expects to amortize the full amounts of goodwill for tax purposes. The company will perform annual testing of goodwill for impairment.
	The amounts of revenue and gross earnings included in the consolidated income statement for the three months ended March 31, 2015 and 2014 are as follow:
	Year Ended March 31, 2015	Total		PIV	PIN	PIC
	Revenue	$	851,252	391,616	216,595	243,041
	Gross Earnings	$	521,303	224,008	137,744	159,551
	Year Ended December 31, 2014	Total		PIV	PIN	PIC
	Revenue	$	-	-	-	-
	Gross Earnings	$	-	-	-	-
	Costs related to the acquisitions, which include legal fees, in the aggregate amount of about $29,500 have been charged directly to operations and are included in legal and professional expenses in the 2014 consolidated income statement.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 5. Goodwill
	The change in the carrying amount of goodwill for the two years ended March 31, 2015 was:
	Balance as of January 1, 2014	$	1,422,670
	Acquisition of goodwill during the year		555,000
	Changes in goodwill during the year		-
	Balance as of December 31, 2014		1,977,670
	Changes in goodwill during the year		-
	Balance as of March 31, 2015	$	1,977,670

Lease_Commitments

Lease Commitments	3 Months Ended
	Mar. 31, 2015
Leases, Operating [Abstract]
Lease Commitments	Note 6. Lease Commitments
	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs, for a total of approximately $6,000 per month. The Lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was given a rental credit of approximately $28,000. This lease was accounted for as an operating lease.
	SMI has a lease for its off-site servers at a cost of approximately $1,092 per month. This lease is accounted for as an operating lease on a month-to-month basis.
	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. Monthly rental amounts in 2014 were $5,437 per month plus approximately $1,674 in utilities, realty taxes, and operating costs.
	SMI has a lease for office space in Dallas, Texas of approximately $880 per month plus approximately $660 in utilities, realty taxes, and operating costs. The lease will expire in August 31, 2015.
	PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016. Monthly rental amounts charged in 2014 were $14,990 per month.
	PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020. Monthly rental amounts charged in 2014 were $15,793 per month. The lease was amended in January 2015 and the rental amount was reduced to $9,543 per month.
	PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016. Monthly rental amounts charged in 2014 were $5,512 per month.
	Expected Lease commitments for the next three years:
	Year	Office Space		Servers		Total
	2015	$	395,904	$	23,328	$	419,232
	2016		412,154		31,104		443,258
	2017		186,516		19,104		205,620
		$	994,574	$	73,536	$	1,068,110

Accounts_Payable_and_Accrued_L

Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Note 7. Accounts Payable and Accrued Liabilities
	As of March 31, 2015 and December 31, 2014, the trade payables and accrued liabilities of the Company were $978,785 and $935,688, respectively.
	Of the total amount as of March 31, 2015, $642,625 was related to ongoing operations representing a balance owing to trade payables. $119,646 was related to accrued payroll and withholdings liabilities, and $216,514 was related to Federal and State income tax owing.
	Of the total amount as of December 31, 2014, $624,141 was related to ongoing operations representing a balance owing to trade payables. $73,461 was related to accrued payroll and withholdings liabilities, and $238,086 was related to Federal and State income tax owing.

Obligations_Under_Capital_Leas

Obligations Under Capital Lease	3 Months Ended
	Mar. 31, 2015
Leases, Capital [Abstract]
Obligations Under Capital Lease	Note 8. Obligations Under Capital Lease
	SMI MRI Machines Capital Lease:
	On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
	The gross amount of the equipment held under capital leases totals $555,000 ($296,083 net book value after accumulated amortization of $258,917) at March 31, 2015.
	Amortization of the capital lease assets is included in the depreciation expense of $$27,750 for the three months ended March 31, 2015 and 2014, respectively.
	SMI X-ray Machine Capital Lease:
	On July 03, 2014 Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $78,250.
	The gross amount of the x-ray machine held under the capital lease is $78,250 ($66,512 net book value after accumulated amortization of $11,738) at March 31, 2015.
	Amortization of the capital lease assets is included in the depreciation expense of $3,913, and $0 for the three months ended March 31, 2015 and 2014, respectively.
	SMI PACS/RIS System Capital Lease:
	On August 19, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $162,333
	The gross amount of the PACS/RIS system held under the capital lease is $162,333 ($148,805 net book value after accumulated amortization of $13,528) at March 31, 2015.
	Amortization of the capital lease assets is included in the depreciation expense of $8,117, and $0 for the three months ended March 31, 2015, and 2014, respectively.
	PV, PN, PC PACS/RIS Capital Lease:
	On November 26, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $167,107.
	The gross amount of the PACS/RIS system held under the capital lease is $167,107 ($157,359 net book value after accumulated amortization of $9,748) at March 31, 2015.
	Amortization of the capital lease assets is included in the depreciation expense of $8,355, and $0 for the three months ended March 31, 2015, and 2014, respectively.
	PV, PN, PC Computers Capital Lease:
	On December 10, 2014 the company has entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813.16, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $25,108.
	The gross amount of the computers held under the capital lease is $25,108 ($22,667 net book value after accumulated amortization of $2,441) at March 31, 2015.
	Amortization of the capital lease assets is included in the depreciation expense of $2,092, and $0 for the three months ended March 31, 2015, and 2014, respectively.
	CTS Computers Lease
	On January 21, 2015 the company has entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the company is to make monthly payments of $651.43, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $20,042 (amount is carried in Canadian dollar).
	The gross amount of the computers held under the capital lease is $20,042 ($18,929 net book value after accumulated amortization of $1,113) at March 31, 2015.
	Amortization of the capital lease assets is included in the depreciation expense of $1,139, and $0 for the three months ended March 31, 2015, and 2014, respectively.
	Minimum future lease payments under the capital leases as of March 31, 2015 are as follow:
	Minimum Lease Payments	Total		SMI	SMI	SMI	PV,PN, PC	PV,PN,PC	CTS
				MRI	PACS/RIS	Xray	PACS/RIS	Computers	Computers
					Lease	Lease	Lease	Lease	Lease
	2015	$	201,486	99,114	28,035	13,458	27,846	27,846	5,186
	2016		241,277	132,152	37,380	17,944	37,128	9,758	6,915
	2017		108,312	-	37,380	17,944	37,128	8,945	6,915
	2018		93,605	-	37,380	17,944	37,128	-	1,153
	2019		83,356	-	34,265	11,963	37,128	-	-
	2020		3,094	-	-	-	3,094	-	-
	Total minimum lease payments		731,130	231,266	174,440	79,254	179,452	46,549	20,169
	Less amount representing interest		74,049	20,870	21,555	10,259	17,367	3,333	665
	Present value of minimum lease payments		657,081	210,397	152,885	68,995	162,085	43,216	19,504
	Less current portion of minimum lease payments		200,053	111,410	29,441	13,984	30,884	7,791	6,544
	Long-term capital lease obligations	$	457,028	98,986	123,444	55,012	131,201	35,425	12,961

Convertible_Notes

Convertible Notes	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Convertible Notes	Note 9. Convertible Notes
	Series B:
	On December 3, 2012, the Company sold, through a private placement to accredited investors, three year 12% convertible notes (“Series B Notes”) in the aggregate principal amount of $1,865,000. On March 27, 2013 the Company sold an additional $150,000 of Series B Notes.
	Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month. The Notes are convertible into common shares of the Company at $0.10 per share. In addition, each holder of Series B Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares issued was 5,315,000 shares of common stock of the Company. $1,865,000 of Series B Notes issued on December 3, 2012 mature on December 31, 2015; and $150,000 of Series B Notes issued March 27, 2013 mature on March 31, 2016.
	For the three months ended March 31, 2015, $60,450 in accrued interest was recorded on the notes and paid.
	In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $244,275. Amortization of the discount for the three months ended March 31, 2015 was $20,356.
	The Details of Series B Notes are as follows:
	Issuance		December 31,			December 31,			Three Months			Three Months			Three Months			March 31,			Maturity
	Date		2014			2014			Ended			Ended			Ended			2015			Date
			Balance			Unamortized			March 31,			March 31,			March 31,			Balance, net
						Discount			2015			2015			2015
						Beginning			Interest			(Payments)			Amortization
						Balance			Accrued						of Debt
															Discount
	3-Dec-12		$	25,000		$	-344		$	750		$	-750		$	94		$	24,750		31-Dec-15
	3-Dec-12			125,000			-5,594			3,750			-3,750			1,244			120,649		31-Dec-15
	3-Dec-12			50,000			-1,031			1,500			-1,500			281			49,250		31-Dec-15
	3-Dec-12			25,000			-344			750			-750			94			24,750		31-Dec-15
	3-Dec-12			25,000			-344			750			-750			94			24,750		31-Dec-15
	3-Dec-12			25,000			-344			750			-750			94			24,750		31-Dec-15
	3-Dec-12			1,500,000			-61,875			45,000			-45,000			16,875			1,455,000		31-Dec-15
	3-Dec-12			50,000			-1,031			1,500			-1,500			281			49,250		31-Dec-15
	3-Dec-12			15,000			-206			450			-450			56			14,850		31-Dec-15
	3-Dec-12			100,000			-3,656			3,000			-3,000			856			97,200		31-Dec-15
	27-Mar-13			25,000			-646			750			-750			129			24,483		31-Mar-16
	27-Mar-13			25,000			-646			750			-750			129			24,483		31-Mar-16
	27-Mar-13			25,000			-646			750			-750			129			24,483		31-Mar-16
	Total		$	2,015,000		$	-76,706		$	60,450		$	-60,450		$	20,356		$	1,958,650
	Following are maturities of the long –term debt in Series B Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2015		$	1,865,000		$	181,350	$	54,800
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	2019			-			-		-
	Total		$	2,015,000		$	185,850	$	56,350
	Series C:
	On May 22, 2014 the Company sold, through private placement to accredited investors, three year 12% convertible notes (“Series C Notes”) in the aggregate principal amount of $95,000.
	The Notes bear interest at a rate of 12% per annum, payable to the holder at 1% per month, with the principal amount due on May 31, 2017. The Notes are convertible into shares of the Company’s common stock at an initial conversion rate of $0.15 per share. In addition, each holder of Series C Notes received shares dependent on the dollar amount of Notes purchased. On August 25, 2014, October 31, 2014 and February 17, 2015 the company sold an additional $75,000, $50,000 and $20,000, respectively of “series C notes”.
	The total number of shares issued was 240,000 shares of common stock of the Company.
	In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $12,695. Amortization of the discount for the year ended December 3, 2014, was $2,081.
	For the three months ended March 31, 2015, $6,800 in accrued interest was recorded on the notes and paid.
	Issuance		December 31,			Three Months		December 31,			Three Months			Three Months			Three Months			March 31,		Maturity
	Date		2014			Ended		2014			Ended			Ended			Ended			2015		Date
			Balance			March 31,		Unamortized			March 31,			March 31,			March 31,			Balance, net
						2015		Discount			2015			2015			2015
						Proceeds		Beginning			Interest			(Payments)			Amortization
								Balance			Accrued						of Debt
																	Discount
	22-May-14		$	50,000		$	-	$	-2,417		$	1,500		$	-1,500		$	250		$	47,833	31-May-17
	22-May-14			22,500			-		-1,088			675			-675			113			21,525	31-May-17
	22-May-14			22,500			-		-1,088			675			-675			113			21,525	31-May-17
	25-Aug-14			50,000			-		-3,419			1,500			-1,500			331			46,912	31-Oct-17
	25-Aug-14			25,000			-		-1,709			750			-750			165			23,456	31-Oct-17
	31-Oct-14			50,000			-		-2,479			1,500			-1,500			218			47,740	31-Oct-17
	17-Feb-15			-			20,000		-1,040			-			-200			29			18,789	17-Feb-18
	Total		$	220,000		$	20,000	$	-13,239		$	6,600		$	-6,800		$	1,219		$	227,780
	Following are maturities of the long –term debt in Series C Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2015		$	-		$	18,300	$	3,657
	2016			-			24,400		4,876
	2017			220,000			12,650		3,429
2018			20,000			400		58
2019			-			-		-
Total		$	240,000		$	55,750	$	12,020
Individually issued Convertible Note:
On March 26, 2014 the Company issued $300,000 in convertible note to a non-affiliate. The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. In addition to interest payments the Company will be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for three years until the note due date of February 27, 2017. The note is convertible into common shares of the Company at $0.15 per share. In addition, the non-affiliate will receive 300,000 shares as part of the note agreement.
For the three months ended March 31, 2015, $7,545 in accrued interest was recorded on the notes and paid.
In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $25,500. Amortization of the discount for the three months ended March 31, 2015 was $2,125.
Summary of the note is as follows:
	March 31,			December 31,
	2015			2014
Convertible note Beginning Balance	$	260,000		$	300,000
Less: unamortized debt discount		-17,000			-19,125
Convertible notes principal, net		243,000			280,875
Less: Payments in Period		-22,545			-66,504
Added: Accrued interest		7,545			26,504
Total Convertible note, net	$	228,000		$	240,875
Less: short term portion, net		55,837			54,263
Long term portion, net	$	172,163		$	186,612
Following are maturity of the individually issued convertible note for each of the next 5 years:
		Principal			Interest		Amortization
		Payments			Payments		of Discount
2015		$	45,000		$	20,339	$	6,375
2016			60,000			20,748		8,500
2017			140,000			2,625		2,125
2018			-			-		-
2019			-			-		-
Total		$	245,000		$	43,712	$	17,000

Promissory_Notes

Promissory Notes	3 Months Ended
	Mar. 31, 2015
Other Liabilities Disclosure [Abstract]
Promissory Notes	Note 10. Promissory Notes
	In June 2014 $64,937 of the SMI acquisition liability that was due as part of SMI acquisition was assigned to a promissory note accruing interest at an annual rate of 12%, and due on February 1, 2015. Interest accrued is to be paid out monthly with the principal amount due on maturity. The note has been fully paid in February 2015.
	In December 2014, the company issued a short term loan payable to a non-related party for $50,000 in proceeds. The note is due on demand and does not accrue interest. For the three months ended March 31, 2015 the company made payments of $41,000 towards the balance and has received additional proceeds of $4,000.
	For the three months ended March 31, 2015 the company has issued loans total of $384,000, the loans terms call for weekly payments of $28,000 towards the principal balance and interest. The final payment is due May 26, 2015.
	A summary of the promissory notes is as follows:
	Promissory notes at January 1, 2014	$	45,015
	Added: Note assigned through December 31, 2014		64,937
	Added: Accrued Interest through December 31, 2014		6,069
	Added: Proceeds through December 31, 2014		50,000
	Less: Payments through December 31, 2014		-31,022
	Promissory notes at December 31, 2014	$	134,999
	Added: Accrued Interest through March 31, 2015		307
	Added: Proceeds through March 31, 2015		388,000
	Less: Payments through March 31, 2015		-273,256
	Added: Discount through March 31, 2015		-22,000
	Promissory notes at March 31, 2015	$	228,050
	Less: Short term portion		228,050
	Long term portion March 31, 2015	$	-

Royalty_Financing

Royalty Financing	3 Months Ended
	Mar. 31, 2015
Royalty Financing
Royalty Financing	Note 11. Royalty Financing
	On October 31, 2014 the company entered into a royalty purchase agreement with Grenville Strategic Royalty Corp. for the amount of $2,000,000. The agreement calls for a monthly payment to the seller based on a percentage of the total of certain revenue items, and subject to a minimum payment amount. For the three months ended March 31, 2015 the company paid a total of $102,122 in royalty payments, and has accrued a total of $71,755 in interest expense. The amount financed is recorded net of discount to be amortized of the term. As of March 31, 2015 the company has recorded discount amortization expense of $76,591. The balance as shown on the consolidated balance sheet as of March 31, 2015 is $2,051,141.

Major_Customers

Major Customers	3 Months Ended
	Mar. 31, 2015
Major Customers
Major Customers	Note 12. Major Customers
	For the three months ending March 31, 2015 and 2015, revenue was derived primarily from radiology services.
	Major customers representing more than 10% of total revenue for the three months ended March 31, 2015 and 2014 are as follow:
		Three Months Ended			Three Months Ended
		31-Mar-15			31-Mar-14
	Customers	Revenue		Revenue	Revenue		Revenue
		amount		percentage	amount		percentage
	Contract A	$	-	0%	$	260,873	22%
	Contract E		216,537	12%		205,727	17%
	Contract F		128,841	17%		132,972	11%
	Contract H	$	75,589	4%	$	74,408	6%
	There were no closing balances for accounts receivable greater than 10% of total balance.

Major_Vendors

Major Vendors	3 Months Ended
	Mar. 31, 2015
Major Vendors
Major Vendors	Note 13. Major Vendors
	The company has one major vendor providing its system software and support. Expenses relating to this vendor for the three months ended March 31, 2015 and 2014 were $13,078 and $13,455, respectively.

Common_Stock_Transactions

Common Stock Transactions	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Common Stock Transactions	Note 14. Common Stock Transactions
	On January 27, 2015 the company granted options as considerations for services provided by the CEO of the company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683.
	On January 27, 2015 the company granted options as considerations for consulting services provided to the company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683.
	On January 27, 2015 the company granted options as considerations for services provided by the CFO of the company. The options are to purchase up to 1,600,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $13,213.
	For the three months ended March 31, 2015, 200,000 shares were issued for services valued at $10,340 based upon the closing price of our common stock at the grant date.
	For the three months ended March 31, 2015, 20,000 shares were issued as part of series C convertible note agreements. The shares were valued at $1,040 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2014, 5,000 shares were issued for services valued at $150 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2014, 300,000 shares were issued as part of individually issued convertible note agreements. The shares were valued at $25,500 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2014, 220,000 shares were issued as part of series C convertible note agreements. The shares were valued at $14,280 based upon the closing price of our common stock at the grant date.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 15. Income Tax
	The Company follows ASC 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between consolidated financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.
	The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure.
	Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.

Going_Concern

Going Concern	3 Months Ended
	Mar. 31, 2015
Going Concern
Going Concern	Note. 16. Going Concern
	As shown in the accompanying consolidated financial statements, the company incurred net losses of $366,574 for the three months ended March 31, 2015 as well as a working capital deficit of $2,438,861. These conditions raise substantial doubt as to if the company’s ability to continue as a going concern. Management plan to raise additional financing in order to continue its operations and fulfil its debt obligations in 2015, but there can be no assurances that the plan will be successful. These consolidated financial statements do not include any adjustments that might be necessary if the company is unable to continue as a going concern.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 17. Subsequent events
	Subsequent to quarter end, the company sold loans in the aggregate principal amount of $336,000. The Company evaluated subsequent events through the date the consolidated financial statements were issued.

Accounting_Policies_Policies

Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation
	Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania. In 2014, the company purchased Partners Imaging Center of Venice, LLC (“PIV”) located in Venice, Florida; Partners Imaging Center of Naples, LLC (“PIN”) located in Naples, Florida; and Partners Imaging Center of Charlotte, LLC (“PIC”) located in Port Charlotte, Florida.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Principle of Consolidation	Principle of Consolidation
	The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions (March 2, 2009, December 10, 2012, and November 1, 2014, respectively) are not included in the consolidated balance sheet.
Reclassification of Accounts	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the March 31, 2015 presentation.
Use of Estimates and Assumptions	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2015, and December 31, 2014, cash includes cash on hand and cash in the bank
Accounts Receivable Credit Risk	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables.
Goodwill and Indefinite Intangible Assets	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisitions date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
Revenue Recognition	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the three months ended March 31, 2015, CTS held seven contracts; one contract that is renewable on a year-to-year basis, three contracts that are renewable in 2014 ,2015, and 2016, and its largest contract, which renewed automatically in 2013 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, PIV, PIN, and PIC revenue is recorded at the time of service.
Cost of Sales	Cost of Sales
	Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Amortization and Depreciation	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the following useful lives.
Stock Based Compensation	Stock Based Compensation
	The company follows ASC 718 to produce an estimated fair value.
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
Fair Value Measurements	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
	Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
	The company does not have assets and liabilities that are carried at fair value on a recurring basis.
Foreign Currency Translation	Foreign Currency Translation
	The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
Income Taxes	Income Taxes
	The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Net Income/ (Loss) Per Share	Net Income (Loss) Per Share
	The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
	Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive.
Recent Accounting Updates	Recent Accounting Updates
	The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Organization_and_Summary_of_Si1

Organization and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings Per Share		Three Months Ended
		March 31,		March 31,
		2015		2014
	Numerator:
	Continuing operations:
	Total Comprehensive Income (Loss)	$	-366,574	$	-39,210
	Total	$	-366,574	$	-39,210
	Total Comprehensive Income (Loss)	$	-366,574	$	-39,210
	Denominator:
	Weighted average number of shares outstanding – basic and diluted		24,098,259		23,350,793
	EPS:
	Basic:
	Total Comprehensive Income (Loss)	$	-0.015	$	-0.002
	Net Income (loss)	$	-0.015	$	-0.002
	Diluted
	Total Comprehensive Income (Loss)	$	-0.015	$	-0.002
	Total Comprehensive Income (Loss)	$	-0.015	$	-0.002

Property_and_Equipment_Tables

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property Plant and Equipment		March 31,		December 31,		Estimated useful lives
		2015		2014
	Computer/Office Equipment	$	462,652	$	435,867	3-7 years
	Medical Equipment		2,123,024		2,123,023	3-7 years
	Leasehold Improvements		843,781		843,781	39 years
	Less: Accumulated Depreciation		-594,103		-463,977
	Net Book Value	$	2,835,354	$	2,938,694

Business_Combination_Tables

Business Combination (Tables)	3 Months Ended
	Mar. 31, 2015
Business Combinations [Abstract]
Schedule of Purchase Price Allocation		Total		PIV	PIN	PIC
	Cash	$	1,800,000	959,286	533,571	307,143
	Total consideration paid	$	1,800,000	959,286	533,571	307,143
Schedule of Recognized Assets Acquired and Liabilities Assumed		Total		PIV	PIN	PIC
	Fixed Assets	$	1,245,000	695,000	375,000	175,000
	Goodwill		555,000	264,286	158,571	132,143
	Net assets purchased	$	1,800,000	959,286	533,571	307,143
Schedule of Revenue and Gross Earnings from Acquired Assets	Year Ended March 31, 2015	Total		PIV	PIN	PIC
	Revenue	$	851,252	391,616	216,595	243,041
	Gross Earnings	$	521,303	224,008	137,744	159,551
	Year Ended December 31, 2014	Total		PIV	PIN	PIC
	Revenue	$	-	-	-	-
	Gross Earnings	$	-	-	-	-

Goodwill_Tables

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Balance as of January 1, 2014	$	1,422,670
	Acquisition of goodwill during the year		555,000
	Changes in goodwill during the year		-
	Balance as of December 31, 2014		1,977,670
	Changes in goodwill during the year		-
	Balance as of March 31, 2015	$	1,977,670

Lease_Commitments_Tables

Lease Commitments (Tables)	3 Months Ended
	Mar. 31, 2015
Leases, Operating [Abstract]
Schedule of Lease Commitments	Year	Office Space		Servers		Total
	2015	$	395,904	$	23,328	$	419,232
	2016		412,154		31,104		443,258
	2017		186,516		19,104		205,620
		$	994,574	$	73,536	$	1,068,110

Obligations_Under_Capital_Leas1

Obligations Under Capital Lease (Tables)	3 Months Ended
	Mar. 31, 2015
Leases, Capital [Abstract]
Schedule of Future Minimum Lease Payments for Capital Leases	Minimum Lease Payments	Total		SMI	SMI	SMI	PV,PN, PC	PV,PN,PC	CTS
				MRI	PACS/RIS	Xray	PACS/RIS	Computers	Computers
					Lease	Lease	Lease	Lease	Lease
	2015	$	201,486	99,114	28,035	13,458	27,846	27,846	5,186
	2016		241,277	132,152	37,380	17,944	37,128	9,758	6,915
	2017		108,312	-	37,380	17,944	37,128	8,945	6,915
	2018		93,605	-	37,380	17,944	37,128	-	1,153
	2019		83,356	-	34,265	11,963	37,128	-	-
	2020		3,094	-	-	-	3,094	-	-
	Total minimum lease payments		731,130	231,266	174,440	79,254	179,452	46,549	20,169
	Less amount representing interest		74,049	20,870	21,555	10,259	17,367	3,333	665
	Present value of minimum lease payments		657,081	210,397	152,885	68,995	162,085	43,216	19,504
	Less current portion of minimum lease payments		200,053	111,410	29,441	13,984	30,884	7,791	6,544
	Long-term capital lease obligations	$	457,028	98,986	123,444	55,012	131,201	35,425	12,961

Convertible_Notes_Tables

Convertible Notes (Tables)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Schedule of Debt	Series B
	Issuance		December 31,			December 31,			Three Months			Three Months			Three Months			March 31,			Maturity
	Date		2014			2014			Ended			Ended			Ended			2015			Date
			Balance			Unamortized			March 31,			March 31,			March 31,			Balance, net
						Discount			2015			2015			2015
						Beginning			Interest			(Payments)			Amortization
						Balance			Accrued						of Debt
															Discount
	3-Dec-12		$	25,000		$	-344		$	750		$	-750		$	94		$	24,750		31-Dec-15
	3-Dec-12			125,000			-5,594			3,750			-3,750			1,244			120,649		31-Dec-15
	3-Dec-12			50,000			-1,031			1,500			-1,500			281			49,250		31-Dec-15
	3-Dec-12			25,000			-344			750			-750			94			24,750		31-Dec-15
	3-Dec-12			25,000			-344			750			-750			94			24,750		31-Dec-15
	3-Dec-12			25,000			-344			750			-750			94			24,750		31-Dec-15
	3-Dec-12			1,500,000			-61,875			45,000			-45,000			16,875			1,455,000		31-Dec-15
	3-Dec-12			50,000			-1,031			1,500			-1,500			281			49,250		31-Dec-15
	3-Dec-12			15,000			-206			450			-450			56			14,850		31-Dec-15
	3-Dec-12			100,000			-3,656			3,000			-3,000			856			97,200		31-Dec-15
	27-Mar-13			25,000			-646			750			-750			129			24,483		31-Mar-16
	27-Mar-13			25,000			-646			750			-750			129			24,483		31-Mar-16
	27-Mar-13			25,000			-646			750			-750			129			24,483		31-Mar-16
	Total		$	2,015,000		$	-76,706		$	60,450		$	-60,450		$	20,356		$	1,958,650
	Series C
	Issuance		December 31,			Three Months		December 31,			Three Months			Three Months			Three Months			March 31,		Maturity
	Date		2014			Ended		2014			Ended			Ended			Ended			2015		Date
			Balance			March 31,		Unamortized			March 31,			March 31,			March 31,			Balance, net
						2015		Discount			2015			2015			2015
						Proceeds		Beginning			Interest			(Payments)			Amortization
								Balance			Accrued						of Debt
																	Discount
	22-May-14		$	50,000		$	-	$	-2,417		$	1,500		$	-1,500		$	250		$	47,833	31-May-17
	22-May-14			22,500			-		-1,088			675			-675			113			21,525	31-May-17
	22-May-14			22,500			-		-1,088			675			-675			113			21,525	31-May-17
	25-Aug-14			50,000			-		-3,419			1,500			-1,500			331			46,912	31-Oct-17
	25-Aug-14			25,000			-		-1,709			750			-750			165			23,456	31-Oct-17
	31-Oct-14			50,000			-		-2,479			1,500			-1,500			218			47,740	31-Oct-17
	17-Feb-15			-			20,000		-1,040			-			-200			29			18,789	17-Feb-18
	Total		$	220,000		$	20,000	$	-13,239		$	6,600		$	-6,800		$	1,219		$	227,780
Schedule of Long-term Debt Instruments		March 31,			December 31,
		2015			2014
	Convertible note Beginning Balance	$	260,000		$	300,000
	Less: unamortized debt discount		-17,000			-19,125
	Convertible notes principal, net		243,000			280,875
	Less: Payments in Period		-22,545			-66,504
	Added: Accrued interest		7,545			26,504
	Total Convertible note, net	$	228,000		$	240,875
	Less: short term portion, net		55,837			54,263
	Long term portion, net	$	172,163		$	186,612
Schedule of Maturities of Long-term Debt	Series B
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2015		$	1,865,000		$	181,350	$	54,800
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	2019			-			-		-
	Total		$	2,015,000		$	185,850	$	56,350
	Series C
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2015		$	-		$	18,300	$	3,657
	2016			-			24,400		4,876
	2017			220,000			12,650		3,429
	2018			20,000			400		58
	2019			-			-		-
	Total		$	240,000		$	55,750	$	12,020
	Individually Issued Convertible Notes
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2015		$	45,000		$	20,339	$	6,375
	2016			60,000			20,748		8,500
	2017			140,000			2,625		2,125
	2018			-			-		-
	2019			-			-		-
	Total		$	245,000		$	43,712	$	17,000

Promissory_Notes_Tables

Promissory Notes (Tables)	3 Months Ended
	Mar. 31, 2015
Other Liabilities Disclosure [Abstract]
Schedule of Promissory Notes	Promissory notes at January 1, 2014	$	45,015
	Added: Note assigned through December 31, 2014		64,937
	Added: Accrued Interest through December 31, 2014		6,069
	Added: Proceeds through December 31, 2014		50,000
	Less: Payments through December 31, 2014		-31,022
	Promissory notes at December 31, 2014	$	134,999
	Added: Accrued Interest through March 31, 2015		307
	Added: Proceeds through March 31, 2015		388,000
	Less: Payments through March 31, 2015		-273,256
	Added: Discount through March 31, 2015		-22,000
	Promissory notes at March 31, 2015	$	228,050
	Less: Short term portion		228,050
	Long term portion March 31, 2015	$	-

Major_Customers_Tables

Major Customers (Tables)	3 Months Ended
	Mar. 31, 2015
Major Customers
Schedule of Revenue by Major Customers		Three Months Ended			Three Months Ended
		31-Mar-15			31-Mar-14
	Customers	Revenue		Revenue	Revenue		Revenue
		amount		percentage	amount		percentage
	Contract A	$	-	0%	$	260,873	22%
	Contract E		216,537	12%		205,727	17%
	Contract F		128,841	17%		132,972	11%
	Contract H	$	75,589	4%	$	74,408	6%

Organization_and_Summary_of_Si2

Organization and Summary of Significant Accounting Policies - Basic and Diluted Earners Per Share (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Numerator
Total comprehensive income (loss)	($366,574)	($39,210)
Denominator
Weighted average number of shares outstanding - basic and diluted	24,098,259	23,350,793
Earnings per Share
Basic earnings per share from total comprehensive income (loss)	($0.02)	($0.00)
Diluted earnings per share from total comprehensive income (loss)	($0.02)	($0.00)

Organization_and_Summary_of_Si3

Organization and Summary of Significant Accounting Policies - PPE Amortization and Depreciation (Details Narrative)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Equipment
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 7 years
Furniture and Fixtures
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	5 - 7 years
Non-compete Contract
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 5 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	39 years	39 years

Organization_and_Summary_of_Si4

Organization and Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Accounts Receivable, Net, Current
Allowance for bad debts	$64,673		$64,673
Bad debt expense (recapture)	0	7,522
Accounts receivable, concentration risk	12.00%		16.00%
Goodwill and Indefinite Intangible Assets
Goodwill	1,977,670		1,977,670	1,422,670
Recognized Share-Based Compensation Expense
Stock-based compensation expense, non-employees	34,683	0
Stock-based compensation expense, employees	58,236	0
Other Income and (Expenses):
Foreign currency gains (losses)	2,236	415
Other comprehensive income (loss)	19,397	1,065
Contract-Based Intangible Assets | SMI
Goodwill and Indefinite Intangible Assets
Goodwill	1,422,670
Contract-Based Intangible Assets | PIC
Goodwill and Indefinite Intangible Assets
Goodwill	132,143
Contract-Based Intangible Assets | PIN
Goodwill and Indefinite Intangible Assets
Goodwill	158,571
Contract-Based Intangible Assets | PIV
Goodwill and Indefinite Intangible Assets
Goodwill	$264,286

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$3,429,457	$3,402,671
Property and equipment, accumulated depreciation	594,103	463,977
Property and equipment, net	2,835,354	2,938,694
Computer/Office Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	462,652	435,867
Property and equipment, estimated useful lives	3-7 years	3-7 years
Medical Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,123,024	2,123,023
Property and equipment, estimated useful lives	3-7 years	3-7 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$843,781	$843,781
Property and equipment, estimated useful lives	39 years	39 years

Property_and_Equipment_Details1

Property and Equipment (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Depreciation expense	$135,724	$39,820
Payments to acquire equipment	32,531		1,875,798
Payment for construction process			$96,470

Business_Combination_Considera

Business Combination - Consideration Transfered (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	$1,800,000
Total consideration paid	1,800,000
PIV
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	959,286
Total consideration paid	959,286
PIN
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	533,571
Total consideration paid	533,571
PIC
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	307,143
Total consideration paid	$307,143

Business_Combination_Recognize

Business Combination - Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) (USD $)	Dec. 31, 2014
Business Acquisition [Line Items]
Fair value fixed assets	$1,245,000
Fair value goodwill	555,000
Fair value net assets purchased	1,800,000
PIV
Business Acquisition [Line Items]
Fair value fixed assets	695,000
Fair value goodwill	264,286
Fair value net assets purchased	959,286
PIN
Business Acquisition [Line Items]
Fair value fixed assets	375,000
Fair value goodwill	158,571
Fair value net assets purchased	533,571
PIC
Business Acquisition [Line Items]
Fair value fixed assets	175,000
Fair value goodwill	132,143
Fair value net assets purchased	$307,143

Business_Combination_Revenue_a

Business Combination - Revenue and Gross Earnings (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Revenue from business combination	$851,252	$0
Gross Earnings from business combination	521,303	0
PIV
Business Acquisition [Line Items]
Revenue from business combination	391,616	0
Gross Earnings from business combination	224,008	0
PIN
Business Acquisition [Line Items]
Revenue from business combination	216,595	0
Gross Earnings from business combination	137,744	0
PIC
Business Acquisition [Line Items]
Revenue from business combination	243,041	0
Gross Earnings from business combination	$159,551	$0

Business_Combination_Details_N

Business Combination (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Share Purchase Agreement, purchase price	$1,800,000
Business combination, costs related to the acquisition	29,500
Business combination, goodwill	$555,000

Goodwill_Details

Goodwill (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Goodwill [Roll Forward]
Goodwill, balance at beginning of period	$1,977,670	$1,422,670
Changes in Goodwill	0	0
Goodwill, Acquired During Period	0	555,000
Goodwill, balance at end of period	$1,977,670	$1,977,670

Lease_Commitments_Details

Lease Commitments (Details) (USD $)	Mar. 31, 2015
Operating Leased Assets [Line Items]
Year 2015	$419,232
Year 2016	443,258
Year 2017	205,620
Operating Leases, Future Minimum Payments Due	1,068,110
Office Space
Operating Leased Assets [Line Items]
Year 2015	395,904
Year 2016	412,154
Year 2017	186,516
Operating Leases, Future Minimum Payments Due	994,574
Computer/Office Equipment
Operating Leased Assets [Line Items]
Year 2015	23,328
Year 2016	31,104
Year 2017	19,104
Operating Leases, Future Minimum Payments Due	$73,536

Lease_Commitments_Details_Narr

Lease Commitments (Details Narrative) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
CTS - Office Space
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$6,000
Leasing arrangements	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs. The Lease renewed in April 2013 for a period of five years and will expire in March 2018.
Rental credit	28,000
SMI - Off Site Server
Operating Leased Assets [Line Items]
Operating lease, minimum payments	1,092
Leasing arrangements	SMI has a lease for its off-site servers. The lease is accounted for as an operating lease on a month-to-month basis.
SMI - Office Space - Pottsville, Pennsylvania
Operating Leased Assets [Line Items]
Operating lease, minimum payments	7,111
Leasing arrangements	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions.
SMI - Office Space - Dallas, Texas
Operating Leased Assets [Line Items]
Operating lease, minimum payments	1,540
Leasing arrangements	SMI has a lease for office space that will expire in August 31, 2015.
PIV
Operating Leased Assets [Line Items]
Operating lease, minimum payments	14,990
Leasing arrangements	PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016.
PIN
Operating Leased Assets [Line Items]
Operating lease, minimum payments	9,543	15,793
Leasing arrangements	PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020. The lease was amended in January 2015 and the rental amount was reduced to $9,543 per month.	PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020
PIC
Operating Leased Assets [Line Items]
Operating lease, minimum payments	$5,512
Leasing arrangements	PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016.

Accounts_Payable_and_Accrued_L1

Accounts Payable and Accrued Liabilities (Details Narrative) (USD $)	Mar. 31, 2015		Dec. 31, 2014
Payables and Accruals [Abstract]
Trade payables and accrued expenses	$978,785		$935,688
Trade payables	$642,625	[1]	$624,141	[2]
[1]	Includes $119,646 was related to accrued payroll and withholdings liabilities, and $216,514 was related to Federal and State income tax owing.
[2]	Includes $73,461 was related to accrued payroll and withholdings liabilities, and $238,086 was related to Federal and State income tax owing.

Obligations_Under_Capital_Leas2

Obligations Under Capital Lease (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Capital Leases Future Minimum Payments Due Rolling Maturity
Obligations Under Capital Lease, long term portion	$428,790	$459,853
SMI - MRI
Capital Leases Future Minimum Payments Due Rolling Maturity
Minimum future lease payments, 2015	99,114
Minimum future lease payments, 2016	132,152
Minimum future lease payments, 2017	0
Minimum future lease payments, 2018	0
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	231,266
Less amount representing interest	20,870
Present value of minimum lease payments	210,397
Less current portion of minimum lease payments	111,410
Obligations Under Capital Lease, long term portion	98,986
SMI - PACS/RIS Lease
Capital Leases Future Minimum Payments Due Rolling Maturity
Minimum future lease payments, 2015	28,035
Minimum future lease payments, 2016	37,380
Minimum future lease payments, 2017	37,380
Minimum future lease payments, 2018	37,380
Minimum future lease payments, 2019	34,265
Minimum future lease payments, 2020	0
Total minimum lease payments	174,440
Less amount representing interest	21,555
Present value of minimum lease payments	152,885
Less current portion of minimum lease payments	29,441
Obligations Under Capital Lease, long term portion	123,444
SMI - Xray Lease
Capital Leases Future Minimum Payments Due Rolling Maturity
Minimum future lease payments, 2015	13,458
Minimum future lease payments, 2016	17,944
Minimum future lease payments, 2017	17,944
Minimum future lease payments, 2018	17,944
Minimum future lease payments, 2019	11,963
Minimum future lease payments, 2020	0
Total minimum lease payments	79,254
Less amount representing interest	10,259
Present value of minimum lease payments	68,995
Less current portion of minimum lease payments	13,984
Obligations Under Capital Lease, long term portion	55,012
PV, PN, PC PACS/RIS Lease
Capital Leases Future Minimum Payments Due Rolling Maturity
Minimum future lease payments, 2015	27,846
Minimum future lease payments, 2016	37,128
Minimum future lease payments, 2017	37,128
Minimum future lease payments, 2018	37,128
Minimum future lease payments, 2019	37,128
Minimum future lease payments, 2020	3,094
Total minimum lease payments	179,452
Less amount representing interest	17,367
Present value of minimum lease payments	162,085
Less current portion of minimum lease payments	30,884
Obligations Under Capital Lease, long term portion	131,201
PV, PN, PC Computers Lease
Capital Leases Future Minimum Payments Due Rolling Maturity
Minimum future lease payments, 2015	27,846
Minimum future lease payments, 2016	9,758
Minimum future lease payments, 2017	8,945
Minimum future lease payments, 2018	0
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	46,549
Less amount representing interest	3,333
Present value of minimum lease payments	43,216
Less current portion of minimum lease payments	7,791
Obligations Under Capital Lease, long term portion	35,425
CTS Computers Lease
Capital Leases Future Minimum Payments Due Rolling Maturity
Minimum future lease payments, 2015	5,186
Minimum future lease payments, 2016	6,915
Minimum future lease payments, 2017	6,915
Minimum future lease payments, 2018	1,153
Minimum future lease payments, 2019	0
Minimum future lease payments, 2020	0
Total minimum lease payments	20,169
Less amount representing interest	665
Present value of minimum lease payments	19,504
Less current portion of minimum lease payments	6,544
Obligations Under Capital Lease, long term portion	12,961
Total Capital Lease Minimum Payments
Capital Leases Future Minimum Payments Due Rolling Maturity
Minimum future lease payments, 2015	201,486
Minimum future lease payments, 2016	241,277
Minimum future lease payments, 2017	108,312
Minimum future lease payments, 2018	93,605
Minimum future lease payments, 2019	83,356
Minimum future lease payments, 2020	3,094
Total minimum lease payments	731,130
Less amount representing interest	74,049
Present value of minimum lease payments	657,081
Less current portion of minimum lease payments	200,053
Obligations Under Capital Lease, long term portion	$457,028

Obligations_Under_Capital_Leas3

Obligations Under Capital Lease (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
SMI - MRI
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$555,000
Capital leases, equipment, net	296,083
Capital leases, depreciation expense	27,750	27,750
Capital leases, accumulated amortization	258,917
Capital leases, leasing arrangements	On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMIBs obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
SMI - PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	162,333
Capital leases, equipment, net	148,805
Capital leases, depreciation expense	8,117	0
Capital leases, accumulated amortization	13,528
Capital leases, leasing arrangements	On August 19, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the CompanyBs subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00.
SMI - Xray Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	78,250
Capital leases, equipment, net	66,512
Capital leases, depreciation expense	3,913	0
Capital leases, accumulated amortization	11,738
Capital leases, leasing arrangements	On July 03, 2014 Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the CompanyBs subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.
PV, PN, PC PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	167,107
Capital leases, equipment, net	157,359
Capital leases, depreciation expense	8,355	0
Capital leases, accumulated amortization	9,748
Capital leases, leasing arrangements	On November 26, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the CompanyBs subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00.
PV, PN, PC Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	25,108
Capital leases, equipment, net	22,667	24,759
Capital leases, depreciation expense	2,092	0
Capital leases, accumulated amortization	2,441	349
Capital leases, leasing arrangements	On December 10, 2014 Company has entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813.16, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.
CTS Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	20,042
Capital leases, equipment, net	18,929
Capital leases, depreciation expense	1,139	0
Capital leases, accumulated amortization	$1,113
Capital leases, leasing arrangements	On January 21, 2015 the company has entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the company is to make monthly payments of $651.43, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.

Convertible_Notes_Details_of_S

Convertible Notes - Details of Series B and C Notes (Details) (USD $)	12 Months Ended	3 Months Ended
	Dec. 31, 2014	Mar. 31, 2015
Debt Instrument [Line Items]
Convertible note, maturity date	1-Feb-15
Series B - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		$25,000
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		94
Convertible note, unamortized debt discount	-344
Convertible note, ending balance		24,750
Convertible note, maturity date		31-Dec-15
Series B - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		125,000
Convertible note, accrued interest		3,750
Convertible note, payments		-3,750
Convertible note, amortization of debt discount		1,244
Convertible note, unamortized debt discount	-5,594
Convertible note, ending balance		120,649
Convertible note, maturity date		31-Dec-15
Series B - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		50,000
Convertible note, accrued interest		1,500
Convertible note, payments		-1,500
Convertible note, amortization of debt discount		281
Convertible note, unamortized debt discount	-1,031
Convertible note, ending balance		49,250
Convertible note, maturity date		31-Dec-15
Series B - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		25,000
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		94
Convertible note, unamortized debt discount	-344
Convertible note, ending balance		24,750
Convertible note, maturity date		31-Dec-15
Series B - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		25,000
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		94
Convertible note, unamortized debt discount	-344
Convertible note, ending balance		24,750
Convertible note, maturity date		31-Dec-15
Series B - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		25,000
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		94
Convertible note, unamortized debt discount	-344
Convertible note, ending balance		24,750
Convertible note, maturity date		31-Dec-15
Series B - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		1,500,000
Convertible note, accrued interest		45,000
Convertible note, payments		-45,000
Convertible note, amortization of debt discount		16,875
Convertible note, unamortized debt discount	-61,875
Convertible note, ending balance		1,455,000
Convertible note, maturity date		31-Dec-15
Series B - Note 8
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		50,000
Convertible note, accrued interest		1,500
Convertible note, payments		-1,500
Convertible note, amortization of debt discount		281
Convertible note, unamortized debt discount	-1,031
Convertible note, ending balance		49,250
Convertible note, maturity date		31-Dec-15
Series B - Note 9
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		15,000
Convertible note, accrued interest		450
Convertible note, payments		-450
Convertible note, amortization of debt discount		56
Convertible note, unamortized debt discount	-206
Convertible note, ending balance		14,850
Convertible note, maturity date		31-Dec-15
Series B - Note 10
Debt Instrument [Line Items]
Convertible note, issuance date		3-Dec-12
Convertible note, beginning balance		100,000
Convertible note, accrued interest		3,000
Convertible note, payments		-3,000
Convertible note, amortization of debt discount		856
Convertible note, unamortized debt discount	-3,656
Convertible note, ending balance		97,200
Convertible note, maturity date		31-Dec-15
Series B - Note 11
Debt Instrument [Line Items]
Convertible note, issuance date		27-Mar-13
Convertible note, beginning balance		25,000
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		129
Convertible note, unamortized debt discount	-646
Convertible note, ending balance		24,483
Convertible note, maturity date		31-Mar-16
Series B - Note 12
Debt Instrument [Line Items]
Convertible note, issuance date		27-Mar-13
Convertible note, beginning balance		25,000
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		129
Convertible note, unamortized debt discount	-646
Convertible note, ending balance		24,483
Convertible note, maturity date		31-Mar-16
Series B - Note 13
Debt Instrument [Line Items]
Convertible note, issuance date		27-Mar-13
Convertible note, beginning balance		25,000
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		129
Convertible note, unamortized debt discount	-646
Convertible note, ending balance		24,483
Convertible note, maturity date		31-Mar-16
Series C - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date		22-May-14
Convertible note, beginning balance		50,000
Convertible note, proceeds		0
Convertible note, accrued interest		1,500
Convertible note, payments		-1,500
Convertible note, amortization of debt discount		250
Convertible note, unamortized debt discount	-2,417
Convertible note, ending balance		47,833
Convertible note, maturity date		31-May-17
Series C - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date		22-May-14
Convertible note, beginning balance		22,500
Convertible note, proceeds		0
Convertible note, accrued interest		675
Convertible note, payments		-675
Convertible note, amortization of debt discount		113
Convertible note, unamortized debt discount	-1,088
Convertible note, ending balance		21,525
Convertible note, maturity date		31-May-17
Series C - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date		22-May-14
Convertible note, beginning balance		22,500
Convertible note, proceeds		0
Convertible note, accrued interest		675
Convertible note, payments		-675
Convertible note, amortization of debt discount		113
Convertible note, unamortized debt discount	-1,088
Convertible note, ending balance		21,525
Convertible note, maturity date		31-May-17
Series C - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date		25-Aug-14
Convertible note, beginning balance		50,000
Convertible note, proceeds		0
Convertible note, accrued interest		1,500
Convertible note, payments		-1,500
Convertible note, amortization of debt discount		331
Convertible note, unamortized debt discount	-3,419
Convertible note, ending balance		46,912
Convertible note, maturity date		31-Oct-17
Series C - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date		25-Aug-14
Convertible note, beginning balance		25,000
Convertible note, proceeds		0
Convertible note, accrued interest		750
Convertible note, payments		-750
Convertible note, amortization of debt discount		165
Convertible note, unamortized debt discount	-1,709
Convertible note, ending balance		23,456
Convertible note, maturity date		31-Oct-17
Series C - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date		31-Oct-14
Convertible note, beginning balance		50,000
Convertible note, proceeds		0
Convertible note, accrued interest		1,500
Convertible note, payments		-1,500
Convertible note, amortization of debt discount		218
Convertible note, unamortized debt discount	-2,479
Convertible note, ending balance		47,740
Convertible note, maturity date		31-Oct-17
Series C - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date		17-Feb-15
Convertible note, beginning balance		0
Convertible note, proceeds		20,000
Convertible note, accrued interest		0
Convertible note, payments		-200
Convertible note, amortization of debt discount		29
Convertible note, unamortized debt discount	-1,040
Convertible note, ending balance		$18,789
Convertible note, maturity date		17-Feb-18

Convertible_Notes_Summary_of_I

Convertible Notes - Summary of Individually Issued Notes (Details) (Individually Issued Convertible Note, USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Individually Issued Convertible Note
Debt Instrument [Line Items]
Convertible notes, beginning balance	$260,000	$300,000
Less: unamortized debt discount	-17,000	-19,125
Convertible notes principal, net	243,000	280,875
Less: Payment in period	-22,545	-66,504
Added: Accrued interest	7,545	26,504
Total convertible notes, net	228,000	240,875
Less: Short term portion, net	55,837	54,263
Long term portion, net	$172,163	$186,612

Convertible_Notes_LongTerm_Deb

Convertible Notes - Long-Term Debt Maturities (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Series B Notes
Debt Instrument [Line Items]
Principal payments, 2015	$1,865,000
Principal payments, 2016	150,000
Principal payments, 2017	0
Principal payments, 2018	0
Principal payments, 2019	0
Interest payments, 2015	181,350
Interest payments, 2016	4,500
Interest payments, 2017	0
Interest payments, 2018	0
Interest payments, 2019	0
Amortization expense, 2015	54,800
Amortization expense, 2016	1,550
Amortization expense, 2017	0
Amortization expense, 2018	0
Amortization expense, 2019	0
Series C Notes
Debt Instrument [Line Items]
Principal payments, 2015	0
Principal payments, 2016	0
Principal payments, 2017	220,000
Principal payments, 2018	20,000
Principal payments, 2019	0
Interest payments, 2015	18,300
Interest payments, 2016	24,400
Interest payments, 2017	12,650
Interest payments, 2018	400
Interest payments, 2019	0
Amortization expense, 2015	3,657
Amortization expense, 2016	4,876
Amortization expense, 2017	3,429
Amortization expense, 2018	58
Amortization expense, 2019	0
Convertible Notes
Debt Instrument [Line Items]
Principal payments, 2015	45,000
Principal payments, 2016	60,000
Principal payments, 2017	140,000
Principal payments, 2018	0
Principal payments, 2019	0
Interest payments, 2015	20,339
Interest payments, 2016	20,748
Interest payments, 2017	2,625
Interest payments, 2018	0
Interest payments, 2019	0
Amortization expense, 2015	6,375
Amortization expense, 2016	8,500
Amortization expense, 2017	2,125
Amortization expense, 2018	0
Amortization expense, 2019	$0

Convertible_Notes_Details_Narr

Convertible Notes (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Convertible notes, payment terms	The loan terms call for weekly payments of $28,000 towards the principal balance and interest.
Convertible notes, interest rate			12.00%
Amortization of debt discount	$112,291	$20,356
Convertible Notes | Individually Issued Convertible Note
Debt Instrument [Line Items]
Convertible notes, sold			300,000
Convertible notes, payment terms			The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. The Company will also be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for 3 years until the note due date of February 27, 2017.
Convertible notes, price per share for conversion of shares of common stock			$0.15
Convertible notes, interest rate			12.00%
Note holder additions			The non-affiliate will receive 300,000 shares as part of the note agreement.
Additional paid in capital and discount	25,500
Amortization of debt discount	2,125
Convertible note, accrued interest	7,545
Private placement, maturity date			27-Feb-17
Common stock issued			300,000
Convertible Notes | Series C Notes
Debt Instrument [Line Items]
Convertible notes, sold	20,000		125,000
Convertible notes, payment terms			Series C Notes bear interest at a rate of 12% per annum, payable to the holder at 1% per month, with principal amount due May 31, 2017.
Convertible notes, price per share for conversion of shares of common stock			$0.15
Convertible notes, interest rate			12.00%
Additional paid in capital and discount	12,695
Amortization of debt discount	2,081
Convertible note, accrued interest	6,800
Private placement, 12% convertible notes, principal amount			95,000
Private placement, maturity date			31-May-17
Common stock issued	240,000
Convertible Notes | Series B Notes
Debt Instrument [Line Items]
Convertible notes, sold				150,000
Convertible notes, payment terms				Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month.
Convertible notes, price per share for conversion of shares of common stock				$0.10
Convertible notes, interest rate				12.00%
Additional paid in capital and discount	244,275			244,275
Amortization of debt discount	20,356
Convertible note, accrued interest	60,450
Private placement, 12% convertible notes, principal amount				$1,865,000
Private placement, maturity date, description				Series B Notes issued December 3, 2012 for $1,865,000 mature on December 31, 2015 and Series B Notes issued March 27, 2013 for $150,000 mature on March 31, 2016.
Common stock issued				5,315,000

Promissory_Notes_Details

Promissory Notes (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Promissory notes, beginning of period	$134,999	$45,015
Proceeds from notes issuances	388,000	50,000
Promissory note assigned		64,937
Accrued interest	307	6,069
Payments through end of period	-273,256	-31,022
Amortization of debt discount	-22,000
Promissory notes, end of period	228,050	134,999
Promissory notes, short-term portion	228,050
Promissory notes, long-term portion	$0	$0

Promissory_Notes_Details_Narra

Promissory Notes (Details Narrative) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Promissory note, accrued interest	$307	$6,069
Promissory note, payments through end of period	41,000
Promissory note, additional proceeds	4,000
Promissory note, assigned		64,937
Promissory note, interest rate		12.00%
Promissory note, maturity date		1-Feb-15
Short term loan payable issued	$384,000	$50,000
Short term loan payable, repayment terms	The loan terms call for weekly payments of $28,000 towards the principal balance and interest.

Royalty_Financing_Details_Narr

Royalty Financing (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2015
Royalty Financing
Royalty payments	$102,122
Accrued interest expense	71,755
Discounted amortization expense	76,591
Accrued royalties	$2,051,141

Major_Customers_Details

Major Customers (Details) (USD $)	3 Months Ended	12 Months Ended	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
Revenue, Major Customer [Line Items]
Major customer percent of revenue	12.00%	16.00%
Contract A
Revenue, Major Customer [Line Items]
Major customer revenues	0		$260,873
Major customer percent of revenue	0.00%		22.00%
Contract E
Revenue, Major Customer [Line Items]
Major customer revenues	216,537		205,727
Major customer percent of revenue	12.00%		17.00%
Contract F
Revenue, Major Customer [Line Items]
Major customer revenues	128,841		132,972
Major customer percent of revenue	17.00%		11.00%
Contract H
Revenue, Major Customer [Line Items]
Major customer revenues	75,589		$74,408
Major customer percent of revenue	4.00%		6.00%

Major_Vendors_Details_Narrativ

Major Vendors (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Major Vendors
Expenses for system software and support	$13,078	$13,455

Common_Stock_Transactions_Deta

Common Stock Transactions (Details Narrative) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Convertible Notes | Individually Issued Convertible Note
Shares issued, convertible notes, shares		300,000
Shares issued, convertible notes, value		$25,500
Convertible Notes | Series C Notes
Shares issued, convertible notes, shares	20,000	220,000
Shares issued, convertible notes, value	1,040	14,280
Common Stock
Shares issued for services, shares	200,000	5,000
Shares issued for services, value	10,340	150
Consulting
Stock options, granted	4,200,000
Stock options, exercise price	$0.15
Stock options, term	2 years 6 months
Stock price at grant date	$0.05
Volatility	70.00%
Risk free interest rate	0.03%
Fair value of stock options at grant date	34,683
Chief Executive Officer
Stock options, granted	4,200,000
Stock options, exercise price	$0.15
Stock options, term	2 years 6 months
Stock price at grant date	$0.05
Volatility	70.00%
Risk free interest rate	0.03%
Fair value of stock options at grant date	34,683
Chief Financial Officer
Stock options, granted	1,600,000
Stock options, exercise price	$0.15
Stock options, term	2 years 6 months
Stock price at grant date	$0.05
Volatility	70.00%
Risk free interest rate	0.03%
Fair value of stock options at grant date	$13,213

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Going Concern
Total Comprehensive Income (Loss)	($366,574)	($39,210)
Working capital deficit	$2,438,861

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative) (Subsequent Event, Loans Payable, USD $)	24-May-15
Subsequent Event | Loans Payable
Subsequent Event [Line Items]
Loan payable	$336,000